MATTHEW HERRMANN: Open Payments
NPI 1760918551 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136,438 in 188 payments from 8 companies in 2025. Trend: 2023 $81,609 · 2024 $73,960 · 2025 $136,438
Speaker / faculty: $77,675Consulting: $27,826Travel & lodging: $25,134Food & beverage: $5,627Gift: $176
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 142 | $129,283 |
| Gilead Sciences, Inc. | 26 | $6,800 |
| EMD Serono, Inc. | 14 | $230 |
| Exact Sciences Corporation | 2 | $42 |
| TOLMAR, INC. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: CABENUVA, APRETUDE, Yeztugo, DOVATO, Serostim, Biktarvy, RUKOBIA, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
